Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 2
2(50.0%)
4Total
Phase 3(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03991481Phase 3Active Not Recruiting

The Cryopreserved vs. Liquid Platelets Trial

Role: collaborator

NCT01638416Phase 3Completed

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Role: collaborator

NCT03508141Phase 2Unknown

Fibrinogen Early In Severe Trauma studY Junior

Role: collaborator

NCT02745041Phase 2Completed

Fibrinogen Early In Severe Trauma studY

Role: collaborator

All 4 trials loaded